Generic Kaftrio 60mg/40mg/80mg granules sachets
NHS hospitals in England used £16,736,418 of indicative cost of Generic Kaftrio 60mg/40mg/80mg granules sachets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 13.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Generic Kaftrio 60mg/40mg/80mg granules sachets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Generic Kaftrio 60mg/40mg/80mg granules sachets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Alder Hey Childrens Nhs Foundation Trust | £1,982,246 |
| Leeds Teaching Hpls Nhs Trust | £1,802,801 |
| King's College Hpl Nhs Foundation Trust | £1,402,178 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,226,906 |
| Manchester University Nhs Ft | £1,218,560 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,099,625 |
| Nottingham University Hospitals Trust | £1,085,019 |
| Sheffield Children's Nhs Ft | £951,478 |
| Oxford University Hospitals Nhs Ft | £692,743 |
| Cambridge Univ Hosp Nhs Foundation Trust | £667,704 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.